BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 21, Issue 39
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (15234)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.
Item 
Count 
PDF922
WORD381
HTML10102
Figures (1-1)339
Tables (1-3)262
 Sum=12006
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1403
Download1825
 Sum=3228
Oct 21, 2015 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Macaluso FS, Maida M, Petta S. Genetic background in nonalcoholic fatty liver disease: A comprehensive review. World J Gastroenterol 2015; 21(39): 11088-11111 [PMID: PMC4607907 DOI: 10.3748/wjg.v21.i39.11088]
URL: https://www.wjgnet.com/1007-9327/full/v21/i39/11088.htm
Number Citing Articles
1
Qing Ye, Bao-Xin Qian, Wei-Li Yin, Feng-Mei Wang, Tao Han, Pavel Strnad. Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls. PLOS ONE 2016; 11(9): e0163423 doi: 10.1371/journal.pone.0163423
2
Aki Juhani Käräjämäki, Risto Bloigu, Heikki Kauma, Y. Antero Kesäniemi, Olli-Pekka Koivurova, Juha Perkiömäki, Heikki Huikuri, Olavi Ukkola. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes. Metabolism 2017; 66: 55 doi: 10.1016/j.metabol.2016.06.009
3
Lei Luo, Ping An, Xinyong Jia, Xiaobian Yue, Sujun Zheng, Shuang Liu, Yu Chen, Wei An, Cheryl A. Winkler, Zhongping Duan. Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study. Frontiers in Genetics 2018; 9 doi: 10.3389/fgene.2018.00662
4
Martijn C.G.J. Brouwers, Nynke Simons, Coen D.A. Stehouwer, Ger H. Koek, Nicolaas C. Schaper, Aaron Isaacs. Relationship Between Nonalcoholic Fatty Liver Disease Susceptibility Genes and Coronary Artery Disease. Hepatology Communications 2019; 3(4): 587 doi: 10.1002/hep4.1319
5
Yusuke Johira, Takashi Nakahara, Takahiro Kinami, Shintaro Yamasaki, Masanari Kosaka, Yuki Shirane, Ryoichi Miura, Serami Murakami, Shigeki Yano, Kei Amioka, Kensuke Naruto, Yuwa Ando, Yumi Kosaka, Kenichiro Kodama, Shinsuke Uchikawa, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Wataru Okamoto, Masami Yamauchi, Tomokazu Kawaoka, C. Nelson Hayes, Masataka Tsuge, Michio Imamura, Hiroshi Aikata, Shiro Oka. Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02851-y
6
T. Herta, J. Fischer, T. Berg. Genetik metabolischer und viraler Lebererkrankungen. Der Gastroenterologe 2017; 12(1): 16 doi: 10.1007/s11377-016-0128-y
7
Weaam Gouda, Esmat Ashour, Yehia Shaker, Wafaa Ezzat. MTP genetic variants associated with non-alcoholic fatty liver in metabolic syndrome patients. Genes & Diseases 2017; 4(4): 222 doi: 10.1016/j.gendis.2017.09.002
8
Sandra Torres, Maximilian J Brol, Fernando Magdaleno, Robert Schierwagen, Frank E. Uschner, Sabine Klein, Cristina Ortiz, Olaf Tyc, Nadine Bachtler, James Stunden, Damien Bertheloot, Ana Kitanovic, Brian Sanchez, Jacob Schrum, William R. Roush, Luigi Franchi, Kate Byth, Eicke Latz, Jonel Trebicka. The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.715765
9
Nina L. Gluchowski, Michel Becuwe, Tobias C. Walther, Robert V. Farese. Lipid droplets and liver disease: from basic biology to clinical implications. Nature Reviews Gastroenterology & Hepatology 2017; 14(6): 343 doi: 10.1038/nrgastro.2017.32
10
Giovanni Targher, Alessandro Mantovani, Anna Alisi, Antonella Mosca, Nadia Panera, Christopher D. Byrne, Valerio Nobili. Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD. Hepatology 2019; 70(1): 142 doi: 10.1002/hep.30625
11
Marta Iruarrizaga-Lejarreta, Enara Arretxe, Cristina Alonso. Using metabolomics to develop precision medicine strategies to treat nonalcoholic steatohepatitis. Expert Review of Precision Medicine and Drug Development 2019; 4(5): 283 doi: 10.1080/23808993.2019.1685379
12
Salvatore Petta, Luca Valenti, Gianluca Svegliati-Baroni, Massimiliano Ruscica, Rosaria Maria Pipitone, Paola Dongiovanni, Chiara Rychlicki, Nicola Ferri, Calogero Cammà, Anna Ludovica Fracanzani, Irene Pierantonelli, Vito Di Marco, Marica Meroni, Debora Giordano, Stefania Grimaudo, Marco Maggioni, Daniela Cabibi, Silvia Fargion, Antonio Craxì. Fibronectin Type III Domain–Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism 2017; 102(8): 2660 doi: 10.1210/jc.2017-00056
13
Timothy E. Thayer, Christian L. Lino Cardenas, Trejeeve Martyn, Christopher J. Nicholson, Lisa Traeger, Florian Wunderer, Charles Slocum, Haakon Sigurslid, Hannah R. Shakartzi, Caitlin O’Rourke, Georgia Shelton, Mary D. Buswell, Hanna Barnes, Leif R. Neitzel, Clara D. Ledsky, Jason Pingcheng Li, Megan F. Burke, Eric Farber-Eger, Daniel S. Perrien, Ravindra Kumar, Kathleen E. Corey, Quinn S. Wells, Kenneth D. Bloch, Charles C. Hong, Donald B. Bloch, Rajeev Malhotra. The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66770-8
14
Xianchao An, Zonglin Yang, Zhengzhuang An. MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR). Medical Science Monitor 2017; 23: 2299 doi: 10.12659/MSM.901377
15
Lilian Fernandes Silva, Jagadish Vangipurapu, Teemu Kuulasmaa, Markku Laakso. An intronic variant in the GCKR gene is associated with multiple lipids. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-46750-3
16
Pori Bayat, masoumeh nezhadali, behnaz Esfandeyari. ASSOCIATION OF RETN GENE POLYMORPHISM WITH SERUM RESISTIN LEVEL, INSULIN RESISTANCE, AND NON-ALCOHOLIC FATTY LIVER DISEASE IN AN IRANIAN POPULATION. Studies in Medical Sciences 2023; 34(10): 632 doi: 10.61186/umj.34.10.632
17
Ibrahim H. Borai, Yehia Mohamed Shaker, Maha Moustafa Kamal, Wafaa M. Ezzat, Esmat Ashour, Mie Afify, Weaam Gouda, Maha M. Elbrashy. Association of nonalcoholic fatty liver disease grades with the plasma cell antigen-1 (PC-1) gene polymorphism. Egyptian Journal of Medical Human Genetics 2018; 19(3): 241 doi: 10.1016/j.ejmhg.2017.12.005
18
Alessandro Mantovani, Chiara Zusi, Andrea Dalbeni, Giorgio Grani, Elena Buzzetti. Risk of Kidney Dysfunction IN Nafld. Current Pharmaceutical Design 2020; 26(10): 1045 doi: 10.2174/1381612825666191026113119
19
Nisreen Nimer, Ibrahim Choucair, Zeneng Wang, Ina Nemet, Lin Li, Janet Gukasyan, Taylor L. Weeks, Naim Alkhouri, Nizar Zein, W.H. Wilson Tang, Michael A. Fischbach, J. Mark Brown, Hooman Allayee, Srinivasan Dasarathy, Valentin Gogonea, Stanley L. Hazen. Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression. Metabolism 2021; 116: 154457 doi: 10.1016/j.metabol.2020.154457
20
Rajiv Heda, Masahiko Yazawa, Michelle Shi, Madhu Bhaskaran, Fuad Zain Aloor, Paul J Thuluvath, Sanjaya K Satapathy. Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect. World Journal of Gastroenterology 2021; 27(17): 1864-1882 doi: 10.3748/wjg.v27.i17.1864
21
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
22
Oksana S. Khukhlina, Oksana D. Liakhovych, Ludmila V. Kaniovska, Olena V. Kaushanska, Alona A. Antoniv, Vera O. Shuper. FEATURES OF SOME ANTHROPOMETRIC INDICES AND INDICES OF INSULIN RESISTANCE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS ON THE BACKGROUND OF OBESITY AND OSTEOARTHRITIS. Wiadomości Lekarskie 2020; 73(4): 746 doi: 10.36740/WLek202004123
23
A. Mantovani, C. Zusi, E. Sani, A. Colecchia, G. Lippi, G.L. Zaza, L. Valenti, C.D. Byrne, C. Maffeis, E. Bonora, G. Targher. Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease. Diabetes & Metabolism 2019; 45(5): 480 doi: 10.1016/j.diabet.2019.01.011
24
Marcello Dallio, Mario Romeo, Antonietta Gerarda Gravina, Mario Masarone, Tiziana Larussa, Ludovico Abenavoli, Marcello Persico, Carmelina Loguercio, Alessandro Federico. Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives. Nutrients 2021; 13(5): 1679 doi: 10.3390/nu13051679
25
Maria J. Guillen-Sacoto, Ariel F. Martinez, Yu Abe, Paul Kruszka, Karin Weiss, Joshua L. Everson, Ramon Bataller, David E. Kleiner, Jerrold M. Ward, Kathleen K. Sulik, Robert J. Lipinski, Benjamin D. Solomon, Maximilian Muenke. Human germline hedgehog pathway mutations predispose to fatty liver. Journal of Hepatology 2017; 67(4): 809 doi: 10.1016/j.jhep.2017.06.008
26
Yvonne P. Dragan. Hepatocellular Carcinoma. 2016; : 65 doi: 10.1007/978-3-319-34214-6_4
27
Wen Cao, Xing An, Longfei Cong, Chaoyang Lyu, Qian Zhou, Ruijun Guo. Application of Deep Learning in Quantitative Analysis of 2‐Dimensional Ultrasound Imaging of Nonalcoholic Fatty Liver Disease. Journal of Ultrasound in Medicine 2020; 39(1): 51 doi: 10.1002/jum.15070
28
Wensheng Liu, Robert D. Baker, Tavleen Bhatia, Lixin Zhu, Susan S. Baker. Pathogenesis of nonalcoholic steatohepatitis. Cellular and Molecular Life Sciences 2016; 73(10): 1969 doi: 10.1007/s00018-016-2161-x
29
Emmi Suomela, Mervi Oikonen, Niina Pitkänen, Ari Ahola-Olli, Johanna Virtanen, Riitta Parkkola, Eero Jokinen, Tomi Laitinen, Nina Hutri-Kähönen, Mika Kähönen, Terho Lehtimäki, Leena Taittonen, Päivi Tossavainen, Antti Jula, Britt-Marie Loo, Vera Mikkilä, Risto Telama, Jorma S.A. Viikari, Markus Juonala, Olli T. Raitakari. Childhood predictors of adult fatty liver. The Cardiovascular Risk in Young Finns Study. Journal of Hepatology 2016; 65(4): 784 doi: 10.1016/j.jhep.2016.05.020
30
Tong-Shuo Zhang, Hua-Lei Qin, Tong Wang, Hai-Tao Li, Hai Li, Shi-Hai Xia, Xiao-Hui Xiang. Bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research. World Journal of Hepatology 2016; 8(33): 1478-1488 doi: 10.4254/wjh.v8.i33.1478
31
Man-Yi Sun, Li Zhang, Song-Li Shi, Jing-Na Lin, Graham R. Wallace. Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis. PLOS ONE 2016; 11(4): e0154337 doi: 10.1371/journal.pone.0154337
32
Yeqing Gu, Xiaohui Wu, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Shunming Zhang, Yawen Wang, Tingjing Zhang, Xuena Wang, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Kaijun Niu, Anne B Newman. High-Normal Thyroid Function Predicts Incident Nonalcoholic Fatty Liver Disease Among Middle-Aged and Older Euthyroid Subjects. The Journals of Gerontology: Series A 2022; 77(1): 197 doi: 10.1093/gerona/glab037
33
Hakan Fotbolcu, Elçin Zorlu. Nonalcoholic fatty liver disease as a multi-systemic disease. World Journal of Gastroenterology 2016; 22(16): 4079-4090 doi: 10.3748/wjg.v22.i16.4079
34
Kana Daijo, Takashi Nakahara, Yuki Inagaki, Maiko Nanba, Yuno Nishida, Shinsuke Uchikawa, Kenichiro Kodama, Kazuki Oya, Kei Morio, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Masami Yamauchi, Tomokazu Kawaoka, Daiki Miki, Masataka Tsuge, Akira Hiramatsu, C Nelson Hayes, Michio Imamura, Hiroshi Aikata, Hidenori Ochi, Kazuaki Chayama. Risk factors for histological progression of non‐alcoholic steatohepatitis analyzed from repeated biopsy cases. Journal of Gastroenterology and Hepatology 2020; 35(8): 1412 doi: 10.1111/jgh.14968
35
Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci. BMC Medicine 2021; 19(1) doi: 10.1186/s12916-021-02087-1
36
Yuhei Aotani, Yuta Kumagai, Masanobu Kameda, Kenji Wada, Toshiyuki Matsunaka, Hiroyasu Morikawa, Hiromichi Horinaka. Improvement of a combined ultrasonic probe used in ultrasonic velocity-change method for evaluation of fat content. Japanese Journal of Applied Physics 2018; 57(7S1): 07LF18 doi: 10.7567/JJAP.57.07LF18
37
Qianwen Li, Ling Wang, Jian Wu, Jing Wang, Yanjie Wang, Xin Zeng. Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003–2018): cross-sectional study. BMJ Open 2022; 12(3): e058517 doi: 10.1136/bmjopen-2021-058517
38
Maggie A. Stanislawski, Jessica Shaw, Elizabeth Litkowski, Ethan M. Lange, Wei Perng, Dana Dabelea, Leslie A. Lange. Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study. The Journal of Pediatrics 2020; 220: 146 doi: 10.1016/j.jpeds.2020.01.031
39
Olfa Khalifa, Khaoula Errafii, Nayla S. Al-Akl, Abdelilah Arredouani. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/8822859
40
Lucía Aubert, Justo Sandino, Elena Gutiérrez-Solís, Florencio García-Martín, Julián Segura, Esteban Porrini, Enrique Morales. Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus. Nephrology Dialysis Transplantation 2022; 37(6): 1125 doi: 10.1093/ndt/gfab176
41
Narges Damavandi, Sirous Zeinali. Association of xenobiotic-metabolizing enzymes (GSTM1 and GSTT 1), and pro-inflammatory cytokines (TNF-α and IL-6) genetic polymorphisms with non-alcoholic fatty liver disease. Molecular Biology Reports 2021; 48(2): 1225 doi: 10.1007/s11033-021-06142-1
42
Lei Liu, Tian Li, Yilie Liao, Yalong Wang, Yang Gao, Haikun Hu, Haipeng Huang, Fang Wu, Ye-Guang Chen, Shuhua Xu, Suneng Fu. Triose Kinase Controls the Lipogenic Potential of Fructose and Dietary Tolerance. Cell Metabolism 2020; 32(4): 605 doi: 10.1016/j.cmet.2020.07.018
43
Shahid Habib. Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy. World Journal of Gastrointestinal Pathophysiology 2024; 15(4): 93606 doi: 10.4291/wjgp.v15.i4.93606
44
Tatyana S. Krolevets, Maria A. Livzan, Maria I. Syrovenko. Liver Fibrosis in Some Patients with Non-Alcoholic Fatty Liver Disease: from Diagnosis to Prognosis. Annals of the Russian academy of medical sciences 2024; 79(4): 293 doi: 10.15690/vramn15829
45
Feizhou Huang, Huaizheng Liu, Zhao Lei, Zhenzhou Li, Tianyi Zhang, Mingshi Yang, Kefu Zhou, Chuanzheng Sun. Long noncoding RNA CCAT1 inhibits miR‐613 to promote nonalcoholic fatty liver disease via increasing LXRα transcription. Journal of Cellular Physiology 2020; 235(12): 9819 doi: 10.1002/jcp.29795
46
Ludovico Abenavoli, Natasa Milic, Laura Di Renzo, Tomislav Preveden, Milica Medić-Stojanoska, Antonino De Lorenzo. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(31): 7006-7016 doi: 10.3748/wjg.v22.i31.7006
47
Ningjian Wang, Chi Chen, Li Zhao, Yi Chen, Bing Han, Fangzhen Xia, Jing Cheng, Qin Li, Yingli Lu. Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis. EBioMedicine 2018; 28: 187 doi: 10.1016/j.ebiom.2017.12.027
48
Giuseppina R Umano, Sonia Caprio, Anna Di Sessa, Naga Chalasani, Daniel J Dykas, Bridget Pierpont, Allen E Bale, Nicola Santoro. The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth. American Journal of Gastroenterology 2018; 113(3): 376 doi: 10.1038/ajg.2018.1
49
Elena Larrieta-Carrasco, Yvonne N. Flores, Luis R. Macías-Kauffer, Paula Ramírez-Palacios, Manuel Quiterio, Eric G. Ramírez-Salazar, Paola León-Mimila, Berenice Rivera-Paredez, Guillermo Cabrera-Álvarez, Samuel Canizales-Quinteros, Zuo-Feng Zhang, Tania V. López-Pérez, Jorge Salmerón, Rafael Velázquez-Cruz. Genetic variants in COL13A1, ADIPOQ and SAMM50 , in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population. Experimental and Molecular Pathology 2018; 104(1): 50 doi: 10.1016/j.yexmp.2018.01.001
50
Fernando Bessone, María Valeria Razori, Marcelo G. Roma. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cellular and Molecular Life Sciences 2019; 76(1): 99 doi: 10.1007/s00018-018-2947-0
51
Kristin Schwerbel, Anne Kamitz, Natalie Krahmer, Nicole Hallahan, Markus Jähnert, Pascal Gottmann, Sandra Lebek, Tanja Schallschmidt, Danny Arends, Fabian Schumacher, Burkhard Kleuser, Tom Haltenhof, Florian Heyd, Sofiya Gancheva, Karl W. Broman, Michael Roden, Hans-Georg Joost, Alexandra Chadt, Hadi Al-Hasani, Heike Vogel, Wenke Jonas, Annette Schürmann. Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation. Journal of Hepatology 2020; 73(4): 771 doi: 10.1016/j.jhep.2020.04.031
52
Katriina Nemes, Fredrik Åberg. Interpreting lipoproteins in nonalcoholic fatty liver disease. Current Opinion in Lipidology 2017; 28(4): 355 doi: 10.1097/MOL.0000000000000427
53
Qing-Feng Sun, Liang-Jie Tang, Ming-Jie Wang, Pei-Wu Zhu, Yang-Yang Li, Hong-Lei Ma, Ou-Yang Huang, Liang Hong, Gang Li, Christopher D. Byrne, Giovanni Targher, Wen-Yue Liu, Yan Lu, Ji-Guang Ding, Ming-Hua Zheng. Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.864570
54
Maddi Oses, Cristina Cadenas‐Sanchez, María Medrano, Arkaitz Galbete, Emiliano Miranda‐Ferrua, Jonatan R. Ruiz, Felix Sánchez‐Valverde, Francisco B. Ortega, Rafael Cabeza, Arantxa Villanueva, Fernando Idoate, Idoia Labayen. Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesity. Pediatric Obesity 2022; 17(9) doi: 10.1111/ijpo.12917
55
Karla Sawada Toda-Oti, José Tadeu Stefano, Ana Mercedes Cavaleiro, Flair José Carrilho, Maria Lúcia Correa-Gianella, Cláudia Pinto Marques de Souza de Oliveira. Association of UCP3 Polymorphisms with Nonalcoholic Steatohepatitis and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease Brazilian Patients. Metabolic Syndrome and Related Disorders 2022; 20(2): 114 doi: 10.1089/met.2020.0104
56
Ben van Ommen, Tim van den Broek, Iris de Hoogh, Marjan van Erk, Eugene van Someren, Tanja Rouhani-Rankouhi, Joshua C Anthony, Koen Hogenelst, Wilrike Pasman, André Boorsma, Suzan Wopereis. Systems biology of personalized nutrition. Nutrition Reviews 2017; 75(8): 579 doi: 10.1093/nutrit/nux029
57
Geru Tao, Guangjie Zhang, Wei Chen, Chao Yang, Yazhuo Xue, Guohua Song, Shucun Qin. A randomized, placebo‐controlled clinical trial of hydrogen/oxygen inhalation for non‐alcoholic fatty liver disease. Journal of Cellular and Molecular Medicine 2022; 26(14): 4113 doi: 10.1111/jcmm.17456
58
Zheng Li, Cheng-Yin Ye, Li Wang, Jin-Mei Li, Lei Yang. Association of Genetic and Environmental Factors with Non-Alcoholic Fatty Liver Disease in a Chinese Han Population. International Journal of Environmental Research and Public Health 2020; 17(14): 5217 doi: 10.3390/ijerph17145217
59
Longman Li, Lulu Huang, Aimin Yang, Xiuming Feng, Zengnan Mo, Haiying Zhang, Xiaobo Yang. Causal Relationship Between Complement C3, C4, and Nonalcoholic Fatty Liver Disease: Bidirectional Mendelian Randomization Analysis. Phenomics 2021; 1(5): 211 doi: 10.1007/s43657-021-00023-0
60
Juan P. Arab, Saul J. Karpen, Paul A. Dawson, Marco Arrese, Michael Trauner. Bile acids and nonalcoholic fatty liver disease. Hepatology 2017; 65(1): 350 doi: 10.1002/hep.28709
61
Ekaterina Efanova, Olga Bushueva, Roman Saranyuk, Anna Surovtseva, Mikhail Churnosov, Maria Solodilova, Alexey Polonikov. Polymorphisms of the GCLC Gene Are Novel Genetic Markers for Susceptibility to Psoriasis Associated with Alcohol Abuse and Cigarette Smoking. Life 2023; 13(6): 1316 doi: 10.3390/life13061316
62
Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova, Milena Peruhova, Georgi H. Vasilev, Georgi V. Vasilev, Metodija Sekulovski, Snezhina Lazova, Milena Gulinac, Latchezar Tomov, Antoaneta Mihova, Tsvetelina Velikova. Microbiome and Genetic Factors in the Pathogenesis of Liver Diseases. Gastroenterology Insights 2023; 14(4): 575 doi: 10.3390/gastroent14040041
63
Jake P. Mann, Robert K. Semple, Matthew J. Armstrong. How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?. Frontiers in Endocrinology 2016; 7 doi: 10.3389/fendo.2016.00145
64
Salvatore Petta, Luca Valenti, Antonino Tuttolomondo, Paola Dongiovanni, Rosaria Maria Pipitone, Calogero Cammà, Daniela Cabibi, Vito Di Marco, Anna Ludovica Fracanzani, Sara Badiali, Valerio Nobili, Silvia Fargion, Stefania Grimaudo, Antonio Craxì. Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease. Hepatology 2017; 66(6): 1885 doi: 10.1002/hep.29395
65
Jinsheng Yu, Sharon Marsh, Junbo Hu, Wenke Feng, Chaodong Wu. The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/2862173
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345